CoChat

Impact of Oral Contraceptives on Sex Hormone-Binding Globulin and Androgen Levels: A Retrospective Study in Women with Sexual Dysfunction

Panzer, Claudia, Wise, Sarah, Fantini, Gemma, Kang, Dongwoo, Munarriz, Ricardo, Guay, Andre, Goldstein, Irwin · 2006 · The Journal of Sexual Medicine
Cited by 148

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Introduction: Oral contraceptives (OCs) have been the preferred method of birth control because of their high rate of effectiveness. OC use, however, has been associated with women's sexual health complaints and androgen insufficiency. OC use is associated with a decrease of androgen ovarian synthesis and an increase in the production of sex hormone-binding globulin (SHBG). There have been limited studies assessing SHBG values after discontinuation of OC use. Aim: To retrospectively investigate SHBG levels before and after discontinuation of OC use. Main Outcome Measure: Sex hormone-binding globulin values were compared at baseline, while on the OC, and well beyond the 7-day half-life of SHBG at 49–120 (mean 80) days and >120 (mean 196) days after discontinuation of OCs. Methods: A total of 124 premenopausal women with sexual health complaints for >6 months met inclusion/exclusion criteria. Three groups of women were defined: (i) “Continued-Users” (N = 62; mean age 32 years) had been on OCs for >6 months and continued taking them; (ii) “Discontinued-Users” (N = 39; mean age 33 years) had been on OCs for >6 months and discontinued them; and (iii) “Never-Users” (N = 23; mean age 36 years) had never taken OCs. Results: Sex hormone-binding globulin values in the “Continued-Users” were four times higher than those in the “Never-User” group (mean 157 ± 13 nmol/L vs. 41 ± 4 nmol/L; P < 0.0001). Despite a decrease in SHBG values after discontinuation of OC use, SHBG levels in “Discontinued-Users” remained elevated in comparison with “Never-Users” (N = 26; P < 0.0001 for >120 days). Conclusion: In women with sexual dysfunction, SHBG changes in “Discontinued-Users” did not decrease to values consistent with “Never-Users.” Long-term sexual, metabolic, and mental health consequences might result as a consequence of chronic SHBG elevation. Does prolonged exposure to the synthetic estrogens of OCs induce gene imprinting and increased gene expression of SHBG in the liver in some women? Prospective research is needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1743-6109.2005.00198.x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 34

  1. Petitti, 2003, Clinical practice. Combination estrogen-progestin oral contraceptives, N Engl J Med, 349, 1443, 10.1056/NEJMcp030751 · DOI · Paper page
  2. Abma, 1997, Fertility, family planning, and women's health: New data from the 1995 National Survey of Family Growth, Vital Health Stat, 23, 1
  3. Mosher, 2004, Use of contraception and use of family planning services in the United States: 1982–2002, Adv Data, 350, 1
  4. Caruso, 2004, Sexual behavior of women taking low-dose oral contraceptive containing 15 microg ethinylestradiol/60 microg gestodene, Contraception, 69, 237, 10.1016/j.contraception.2003.11.001 · DOI
  5. Adams, 1978, Rise in female-initiated sexual activity at ovulation and its suppression by oral contraceptives, N Engl J Med, 299, 1145, 10.1056/NEJM197811232992101 · DOI · Paper page
  6. Sanders, 2001, A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation, Contraception, 64, 51, 10.1016/S0010-7824(01)00218-9 · DOI · Paper page
  7. Shifren, 2004, The role of androgens in female sexual dysfunction, Mayo Clin Proc, 79, S19, 10.1016/S0025-6196(19)30668-8 · DOI
  8. Guay, 2004, Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part B: Reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction, Int J Impot Res, 16, 121, 10.1038/sj.ijir.3901176 · DOI
  9. Guay, 2002, Testosterone insufficiency in women: Fact or fiction?, World J Urol, 20, 106, 10.1007/s00345-002-0267-2 · DOI
  10. Thijssen, 1988, Hormonal and nonhormonal factors affecting sex hormone-binding globulin levels in blood, Ann NY Acad Sci, 538, 280, 10.1111/j.1749-6632.1988.tb48872.x · DOI
  11. Fotherby, 1992, Clinical experience and pharmacological effects of an oral contraceptive containing 20 micrograms oestrogen, Contraception, 46, 477, 10.1016/0010-7824(92)90151-I · DOI
  12. Fotherby, 1995, Twelve years of clinical experience with an oral contraceptive containing 30 micrograms ethinyloestradiol and 150 micrograms desogestrel, Contraception, 51, 3, 10.1016/0010-7824(94)00010-T · DOI
  13. Jung-Hoffmann, 1987, Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone, Am J Obstet Gynecol, 156, 199, 10.1016/0002-9378(87)90238-9 · DOI
  14. Refn, 1990, Clinical and hormonal effects of two contraceptives: Correlation to serum concentrations of levonorgestrel and gestodene, Contraception, 41, 259, 10.1016/0010-7824(90)90067-6 · DOI
  15. Coenen, 1996, Changes in androgens during treatment with four low-dose contraceptives, Contraception, 53, 171, 10.1016/0010-7824(96)00006-6 · DOI
  16. Samsioe, 2002, The role of ERT/HRT, Best Pract Res Clin Obstet Gynaecol, 16, 371, 10.1053/beog.2002.0286 · DOI
  17. Edmunds, 1990, Estrogen and androgen regulation of sex hormone binding globulin secretion by a human liver cell line, J Steroid Biochem Mol Biol, 37, 733, 10.1016/0960-0760(90)90358-R · DOI
  18. White, 2005, Effect of oral versus transdermal steroidal contraceptives on androgenic markers, Am J Obstet Gynecol, 192, 2055, 10.1016/j.ajog.2005.02.067 · DOI
  19. Browne-Martin, 2001, Regulation of sex hormone-binding globulin secretion in human hepatoma G2 cells, Steroids, 66, 605, 10.1016/S0039-128X(01)00094-0 · DOI
  20. Odlind, 2002, Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?, Acta Obstet Gynecol Scand, 81, 482
  21. Koulianos, 2000, Treatment of acne with oral contraceptives: Criteria for pill selection, Cutis, 66, 281
  22. Berglund, 2002, Vulvar pain, sexual behavior and genital infections in a young population: A pilot study, Acta Obstet Gynecol Scand, 81, 738, 10.1034/j.1600-0412.2002.810809.x · DOI
  23. Bohm-Starke, 2004, Decreased mechanical pain threshold in the vestibular mucosa of women using oral contraceptives: A contributing factor in vulvar vestibulitis?, J Reprod Med, 49, 888
  24. Bouchard, 2002, Use of oral contraceptive pills and vulvar vestibulitis: A case–control study, Am J Epidemiol, 156, 254, 10.1093/aje/kwf037 · DOI · Paper page
  25. Sjoberg, 1997, Vulvar vestibulitis in the north of Sweden. An epidemiologic case–control study:, J Reprod Med, 42, 166
  26. Bazin, 1994, Vulvar vestibulitis syndrome: An exploratory case–control study, Obstet Gynecol, 83, 47
  27. Kuhnz, 1992, Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation, Contraception, 46, 455, 10.1016/0010-7824(92)90149-N · DOI
  28. Selby, 1990, Sex hormone binding globulin: Origin, function and clinical significance, Ann Clin Biochem, 27, 532, 10.1177/000456329002700603 · DOI · Paper page
  29. Guay, 2004, Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part A. Serum androgen levels in women aged 20–49 years with no complaints of sexual dysfunction, Int J Impot Res, 16, 112, 10.1038/sj.ijir.3901178 · DOI
  30. Guay, 2002, Screening for androgen deficiency in women: Methodological and interpretive issues, Fertil Steril, 77, S83, 10.1016/S0015-0282(02)02965-5 · DOI
  31. McLachlan, 2001, Gene imprinting in developmental toxicology: A possible interface between physiology and pathology, Toxicol Lett, 120, 161, 10.1016/S0378-4274(01)00295-8 · DOI
  32. Migliaccio, 2000, Transient estrogen exposure of female mice during early development permanently affects osteoclastogenesis in adulthood, Bone, 27, 47, 10.1016/S8756-3282(00)00286-6 · DOI
  33. Csaba, 1987, Hormonal imprinting of the microsomal enzyme system in adults. Microsomal activity change in response to estrogen (DES, AE) treatment during liver regeneration, Horm Metab Res, 19, 493, 10.1055/s-2007-1011861 · doi:10.1055/s-2007-1011861
  34. Csaba, 1986, Hormonal imprinting by steroids: A single neonatal treatment with diethylstilbestrol or allylestrenol gives rise to a lasting decrease in the number of rat uterine receptors, Acta Physiol Hung, 67, 207

Cited by

See all 148

Metadata

Authors
Panzer, C., Wise, S., Fantini, G., Kang, D., Munarriz, R., Guay, A., & Goldstein, I.
Venue
The Journal of Sexual Medicine
Published
2006-01-01
Volume
3
Issue
1
Pages
104-113
ISSN
  • 1743-6095 (ISSN-L)
  • 1743-6109
OpenAlex
W2143140507
Cited by
148
References
9
FWCI
9.63
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of Oral Contraceptives on Sex Hormone-Binding Globulin and Androgen Levels: A Retrospective Study in Women with Sexual Dysfunction. https://app.cochat.ai/papers/10.1111/j.1743-6109.2005.00198.x
The paper
Panzer, C., Wise, S., Fantini, G., Kang, D., Munarriz, R., Guay, A., & Goldstein, I. (2006). Impact of Oral Contraceptives on Sex Hormone-Binding Globulin and Androgen Levels: A Retrospective Study in Women with Sexual Dysfunction. The Journal of Sexual Medicine. https://doi.org/10.1111/j.1743-6109.2005.00198.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.